Sri Mudumba

Sri Mudumba has a diverse and extensive work experience in the pharmaceutical industry. They currently hold the position of Chief Research & Development Officer at PYC Therapeutics. Prior to this, they held various roles at Santen, including Vice President, Retina Franchise Lead & Global Pharmaceutical Development, Senior Director & Head of Pharmaceutical Development, and VP, Modality Innovation. They also worked at Genentech, Inc. as a Scientist, Drug Delivery. Additionally, they have held positions at MacuSight, Inc. as Director of Product Development and Director of Process Development, at Corium International Inc. as Group Leader, at PowderJect Technologies, Inc. as Group Leader, at Cygnus Inc. as Staff Scientist, at UCSF in Dr. Howard Maibach's Lab as a Postdoctoral Fellow, at ALZA Corporation as a Drug Safety Associate, and at Neurex Corporation as a Summer Intern.

Sri Mudumba obtained a PhD in Pharmaceutical Sciences from the University of the Pacific from 1991 to 1997. There is no available information about the specific years or degrees earned from Jadavpur University or Kakatiya University.